Positive allosteric modulator activity at human GLP-1R expressed in HEK293 cells assessed as potentiation of GLP-1(7-36)NH2 induced cAMP accumulation at 10 uM preincubated for 15 mins followed by GLP-1(7-36)NH2 addition and measured after 15 mins relative to control
Invivo positive allosteric modulator activity at GLP-1R in 12 hrs fasted Wistar rat assessed as reduction in time spend in hyperglycemia at 1 mg/kg, ip administered 30 mins prior to glucose load injection and measured upto 120 mins
Invivo positive allosteric modulator activity at GLP-1R in 12 hrs fasted Wistar rat assessed as potentiation of exendin-4 induced feeding suppression at 1 ug/kg, icv measured upto 240 mins post injection
Positive allosteric modulator activity at GLP-1R in rat INS1 beta-cells assessed potentiation of GLP-1(7-36)NH2 induced insulin secretion at 1 uM incubated for 30 mins in presence of 15 mM of glucose by ELISA
Positive allosteric modulator activity at human GLP-1R expressed in HEK293 cells assessed as potentiation of GLP-1(7-36)NH2 induced cAMP accumulation at 0.1 nM preincubated for 15 mins followed by GLP-1(7-36)NH2 addition and measured after 15 mins relative to GLP-1
Positive allosteric modulator activity at GLP-1R in rat INS1 beta-cells assessed potentiation of GLP-1(7-36)NH2 induced insulin secretion incubated for 30 mins in presence of high glucose condition by ELISA
Positive allosteric modulator activity at GLP-1R in rat INS1 beta-cells assessed potentiation of GLP-1(7-36)NH2 induced insulin secretion incubated for 30 mins in presence of 0.2 nM of GLP-1 by ELISA
Positive allosteric modulator activity at GLP-1R in rat INS1 beta-cells assessed potentiation of GLP-1(7-36)NH2 induced insulin secretion at 0.1 nM incubated for 30 mins in presence of exendin(9-39)NH2 by ELISA